Literature DB >> 7897226

Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury.

T P Shanley1, H Schmal, H P Friedl, M L Jones, P A Ward.   

Abstract

IL-10 has regulatory effects in vitro on cytokine production by activated macrophages. In the IgG immune complex model of lung injury, exogenously administered IL-10 has been shown to suppress in vivo formation of TNF-alpha, up-regulation of vascular ICAM-1, neutrophil recruitment, and ensuing lung injury. In the current study, we sought to determine whether endogenous IL-10 is playing a regulatory role in the lung inflammatory response. On the basis of lung mRNA and ELISA measurements, IL-10 induction was found during development of inflammation in the IgG immune complex model of lung injury. Blocking of IL-10 by Ab resulted in a 52% increase in lung vascular permeability, a 56% increase in TNF-alpha activity in bronchoalveolar lavage fluids, and a 47 to 48% increase in bronchoalveolar lavage neutrophils and lung myeloperoxidase content. These findings suggest that IL-10 is an important natural regulator of lung inflammatory injury after deposition of IgG immune complexes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7897226

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  19 in total

1.  Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE.

Authors:  J Rönnelid; A Tejde; L Mathsson; K Nilsson-Ekdahl; B Nilsson
Journal:  Ann Rheum Dis       Date:  2003-01       Impact factor: 19.103

Review 2.  The role of inflammatory mediators in the failing heart: immunomodulation of cytokines in experimental models of heart failure.

Authors:  A Matsumori; S Sasayama
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

3.  Regulatory effects of interleukin-6 in immunoglobulin G immune-complex-induced lung injury.

Authors:  T P Shanley; J L Foreback; D G Remick; T R Ulich; S L Kunkel; P A Ward
Journal:  Am J Pathol       Date:  1997-07       Impact factor: 4.307

4.  Role of T-lymphocytes in the resolution of endotoxin-induced lung injury.

Authors:  P E Morris; J Glass; R Cross; D A Cohen
Journal:  Inflammation       Date:  1997-06       Impact factor: 4.092

5.  Ureaplasma urealyticum modulates endotoxin-induced cytokine release by human monocytes derived from preterm and term newborns and adults.

Authors:  W M Manimtim; J D Hasday; L Hester; K D Fairchild; J C Lovchik; R M Viscardi
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

Review 6.  Endogenous regulation of the acute inflammatory response.

Authors:  Peter A Ward; Alex B Lentsch
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

7.  Effect of IL-10 on neutrophil recruitment and survival after Pseudomonas aeruginosa challenge.

Authors:  Lei Sun; Ren-Feng Guo; Michael W Newstead; Theodore J Standiford; Demetrio R Macariola; Thomas P Shanley
Journal:  Am J Respir Cell Mol Biol       Date:  2008-12-18       Impact factor: 6.914

8.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13.

Authors:  A B Lentsch; T P Shanley; V Sarma; P A Ward
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

9.  Protective actions of aspirin-triggered (17R) resolvin D1 and its analogue, 17R-hydroxy-19-para-fluorophenoxy-resolvin D1 methyl ester, in C5a-dependent IgG immune complex-induced inflammation and lung injury.

Authors:  Huifang Tang; Yanlan Liu; Chunguang Yan; Nicos A Petasis; Charles N Serhan; Hongwei Gao
Journal:  J Immunol       Date:  2014-08-29       Impact factor: 5.422

Review 10.  Biology of TNFalpha and IL-10, and their imbalance in heart failure.

Authors:  Kuljeet Kaur; Sanjiv Dhingra; Jan Slezak; Anita K Sharma; Anju Bajaj; Pawan K Singal
Journal:  Heart Fail Rev       Date:  2008-08-19       Impact factor: 4.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.